291 related articles for article (PubMed ID: 33797690)
1. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis.
Wu T; Lei MS; Gao XZ; Xiong TG; Yang K; Gong Q; Tang R; Tian YP; Fu XH
Biochem Genet; 2021 Oct; 59(5):1311-1325. PubMed ID: 33797690
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis.
Lu M; Qin X; Zhou Y; Li G; Liu Z; Yue H; Geng X
Biomed Pharmacother; 2020 Oct; 130():110566. PubMed ID: 32755793
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.
Lu WX
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7356-7368. PubMed ID: 31539122
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
Chang W; Wang Y; Li W; Geng Z
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
[TBL] [Abstract][Full Text] [Related]
6. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
Jiang T; Wang C; Zhu Y; Han H
J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
[TBL] [Abstract][Full Text] [Related]
7. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
[TBL] [Abstract][Full Text] [Related]
8. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
9. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma.
Zhu CY; Fan CR; Zhang YL; Sun QX; Yan MJ; Wei W; Liu GF; Liu JJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
Sun ZP; Tan ZG; Peng C; Yi WM
J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA SNHG16 targets miR-146a-5p/CCL5 to regulate LPS-induced WI-38 cell apoptosis and inflammation in acute pneumonia.
Zhou Z; Zhu Y; Gao G; Zhang Y
Life Sci; 2019 Jul; 228():189-197. PubMed ID: 31071307
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y
J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837
[TBL] [Abstract][Full Text] [Related]
14. The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma.
Peng T; Deng X; Tian F; Li Z; Jiang P; Zhao X; Chen G; Chen Y; Zheng P; Li D; Wang S
Int J Oncol; 2019 Sep; 55(3):657-670. PubMed ID: 31322171
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
[TBL] [Abstract][Full Text] [Related]
16. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis.
Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A
Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475
[TBL] [Abstract][Full Text] [Related]
17. Circ-LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR-556-5p and miR-567 mediated YY1 activation.
Xu Y; Gao P; Wang Z; Su Z; Liao G; Han Y; Cui Y; Yao Y; Zhong X
J Cell Mol Med; 2021 Apr; 25(7):3226-3238. PubMed ID: 33675150
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
